Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

BACKGROUND: Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stopping. CD therefore serves as a timely and novel paradigm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Whitwell, Sophia CL, Mathew, Christopher G, Lewis, Cathryn M, Forbes, Alastair, Watts, Sally, Sanderson, Jeremy, Hollands, Gareth J, Prevost, A Toby, Armstrong, David, Kinmonth, Ann Louise, Sutton, Stephen, Marteau, Theresa M
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3036624/
https://ncbi.nlm.nih.gov/pubmed/21247480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2458-11-44
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares